趙久良

系統性紅斑狼瘡、類風濕關節炎、乾燥綜合徵、強直性脊柱炎等疑難風濕免疫病。 ^[1] 

系統性紅斑狼瘡、類風濕關節炎、乾燥綜合徵、強直性脊柱炎等疑難風濕免疫病的診療策略。

1.抗膜突蛋白抗體在結締組織病相關肺高壓肺血管重塑機制研究，北京協和醫學院“中央高校基本科研業務費”項目.

2.中國產科抗磷脂綜合徵患者單核苷酸多態性（SNP）研究，北京協和醫院傑出青年基金項目. ^[1] 

1.2015年全國風濕科中青年醫師演講精英匯英語演講比賽一等獎.

2.2014年全國風濕病學年會優秀論文獎.

3.2014年北京協和醫院優秀臨牀帶教老師.

4.2013年北京協和醫院優秀員工獎.

5.2010年日本風濕病學年會國際青年獎.

國家中醫藥管理局名詞術語成果轉化與規範推廣項目編審專家

北京醫學會風濕病學分會青年副主委

亞太風濕病聯盟學術委員會青年副主委

《協和醫學雜誌》青年委員

1.Zhao, J., Bai, W., Zhu, P., Zhang, X., Liu, S., Wu, L., et al., Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus. Lupus, 2016. 25(6): 652-7.

2.Zhao, J., Wang, Q., Liu, Y., Tian, Z., Guo, X., Wang, H., et al., Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Int J Cardiol, 2017. 236: 432-437.

3.Zhao, J., Wang, Y., Wang, Q., Li, M. and Zeng, X., Response to letter "Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: Methodological issues". Int J Cardiol, 2017. 249: 418.

4.Zhao, J.L., Sun, Y.D., Zhang, Y., Xu, D., Wang, Q., Li, M.T., et al., [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome]. Zhonghua Nei Ke Za Zhi, 2016. 55(5): 386-91.

5.Zhao, J.L., Zhang, Y., Zhang, S., Li, J., Wang, Q., Zhao, Y., et al., [The 451(th) case: intermittent rash, fever and headache]. Zhonghua Nei Ke Za Zhi, 2016. 55(7): 578-81.

6.Li, M., Wang, Q.,Zhao, J., Li, Z., Ye, Z., Li, C., et al., Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus, 2014. 23(10): 1085-91.

7.Sun, Y.D.,Zhao, J.L., Zhang, P., Wang, Q. and Li, M.T., [The 460th case: lower extremity edema, positive fecal occult blood]. Zhonghua Nei Ke Za Zhi, 2017. 56(12): 974-976.

8.Li, X.,Zhao, J., Wang, Q., Fei, Y. and Zhao, Y., ANCA-Associated Systemic Vasculitis Presenting With Hypertrophic Spinal Pachymeningitis: A Report of 2 Cases and Review of Literature. Medicine (Baltimore), 2015. 94(46): e2053.

9.Li, Y., Ren, X.Y., Sun, F., Wang, P.,Zhao, J.L.,Wu, Q.J., et al., [The 456th case: polyarthritis, dry cough, dyspnea on exertion]. Zhonghua Nei Ke Za Zhi, 2017. 56(5): 388-392.

10.Dong, R., Weng, L., Guo, T., Zhu, T.N.,Zhao, J.L., Wu, Q.J., et al., [The 455th case: swollen leg, jaundice and mental disturbance]. Zhonghua Nei Ke Za Zhi, 2017. 56(4): 316-320.

11.Xu, D., Li, M.T., Hou, Y., Wang, Q., Hu, C.J., Song, N.,Zhao, J., et al., Clinical characteristics of systemic sclerosis patients with digital ulcers in China. Clin Exp Rheumatol, 2013. 31(2 Suppl 76): 46-9.

12.Huang, J., Li, M., Tian, Z., Hsieh, E., Wang, Q., Liu, Y.,Zhao, J.,et al., Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. Clin Exp Rheumatol, 2014. 32(6 Suppl 86): S-115-21.

13.Li, J., Leng, X., Li, Z., Ye, Z., Li, C., Li, X.,Zhao, J.,et al., Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus. J Immunol Res, 2014. 2014: 809389.

14.Zhang, Y., Fei, Y., Niu, J., Ren, H.,Zhao, J., Wang, Q., et al., [Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease]. Zhonghua Yi Xue Za Zhi, 2014. 94(39): 3056-61.

15.Tian, X., Li, M., Ye, Z., Zhang, X., Liu, S., Wu, L.,Zhao, J.,et al., Related factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV. Int J Rheum Dis, 2015. 18(6): 654-60.

16.Xu, N.,Zhao, J., Liu, J., Wu, D., Zhao, L., Wang, Q., et al., Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study. Medicine (Baltimore), 2015. 94(4): e419.

17.Zhang, S.Z., Xu, D., Li, M.T., Hou, Y., Wang, Q., Tian, Z.,Zhao, J.L., et al., Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China. Clin Exp Rheumatol, 2015. 33(4 Suppl 91): S106-10.

18.Wang, Z., Wang, Y., Zhu, R., Tian, X., Xu, D., Wang, Q.,Zhao, J.,et al., Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore), 2015. 94(17): e794.

19.Xu, D., You, X., Wang, Z., Zeng, Q., Xu, J., Jiang, L.,Zhao, J.,et al., Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus. PLoS One, 2015. 10(8): e0134451.

20.Zhang, S., Su, J., Li, X., Zhang, X., Liu, S., Wu, L.,Zhao, J.,et al., Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus. Lupus, 2015. 24(12): 1267-75.

21.Huang, C., Li, M., Liu, Y., Wang, Q., Guo, X.,Zhao, J., et al., Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients. Medicine (Baltimore), 2016. 95(10): e2761.

22.Li, J., Yang, Y.,Zhao, J., Li, M., Tian, X. and Zeng, X., The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu's arteritis. Sci Rep, 2016. 6: 38687.

23.Qian, J., Li, M.,Zhao, J., Wang, Q., Tian, Z. and Zeng, X., The role of anti-U1 RNP positivity in predicting survival of CTD-associated PAH: Angel or demon? Comment on the article by Sobanski et al. Arthritis Rheumatol, 2016.

24.Qian, J., Wang, Y., Huang, C., Yang, X.,Zhao, J., Wang, Q., et al., Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis. Autoimmun Rev, 2016. 15(3): 250-7.

25.Wang, H., Guo, X., Lai, J., Wang, Q., Tian, Z., Liu, Y.,Zhao, J.,et al., Predictors of health-related quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension. Clin Exp Rheumatol, 2016. 34(2): 291-5.

26.Zhang, S., Wu, Z., Chen, S., Li, J., Wen, X., Li, L.,Zhao, J.,et al., Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome. Sci Rep, 2016. 6: 23839.

27.Zhang, S., Wu, Z., Li, J., Li, P., Chen, S., Wen, X.,Zhao, J.,et al., Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events. Rheumatol Int, 2016.

28.Chinese Takayasu arteritis patients. Medicine (Baltimore), 2016. 95(27): e4069.

29.Chen, Z., Li, J., Yang, Y., Li, H.,Zhao, J., Sun, F., et al., The renal artery is involved in Chinese Takayasu's arteritis patients. Kidney Int, 2017.

30.Cheng, Y., Li, M.,Zhao, J., Ye, Z., Li, C., Li, X., et al., Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE. Int J Rheum Dis, 2017.

31.Hu, C., Li, M., Liu, J., Qian, J., Xu, D., Zhang, S.,Zhao, J.L., et al., Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE. Sci Rep, 2017. 7(1): 7617.

32.Leng, X., Li, M., Li, X., Zhang, X., Liu, S., Wu, L.,Zhao, J.,et al., Chinese lupus treatment and research group (CSTAR) registry: X. family history in relation to lupus clinical and immunological manifestations. Clin Exp Rheumatol, 2017.

33.Li, J., Li, H., Sun, F., Chen, Z., Yang, Y.,Zhao, J., et al., Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis. J Rheumatol, 2017.

34.Li, J., Sun, F., Chen, Z., Yang, Y.,Zhao, J., Li, M., et al., The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years. Arthritis Res Ther, 2017. 19(1): 107.

35.Li, J., Zhu, M., Li, M., Zheng, W.,Zhao, J., Tian, X., et al., Cause of death in

36.Peng, L., Wang, Z., Li, M., Wang, Y., Xu, D., Wang, Q.,Zhao, J.,et al., Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study. Clin Rheumatol, 2017. 36(12): 2727-2732.

37.Wang, J., Qian, J., Wang, Y.,Zhao, J., Wang, Q., Tian, Z., et al., Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis. Lupus, 2017: 961203317702255.

38.Wu, C.Y., Li, C.F., Wu, Q.J., Xu, J.H., Jiang, L.D.,Zhao, J.L.,Gong, L., et al., Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China. Chin Med J (Engl), 2017. 130(11): 1276-1282.

39.Xu, W.,Zhao, J., Zhu, Y. and Zhang, W., Cerebroretinal microangiopathy with calcifications and cysts: A case report. Medicine (Baltimore), 2017. 96(1): e5545.

40.Yang, H.,Zhao, J., Li, Y., Lv, F., Zhang, S. and Li, Y., Successful treatment of Type B insulin resistance with mixed connective tissue disease by pulse glucocorticoids and cyclophosphamide. J Diabetes Investig, 2017.

41.Zhang, S., Wu, Z., Li, J., Wen, X., Li, L., Zhang, W.,Zhao, J.,et al., Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. Clin Rheumatol, 2017. 36(2): 407-412.

42.Zhou, J., Chen, Z., Li, J., Yang, Y.,Zhao, J., Chen, H., et al., The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis. Clin Exp Rheumatol, 2017. 35 Suppl 103(1): 171-175.

《協和內科住院醫師手冊》，中國協和醫科大學出版社，趙久良主編，2014年出版.